These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Distribution kinetics of solutes in the isolated in-situ perfused rat head using the multiple indicator dilution technique and a physiological two-barrier model. Foster KA, Weiss M, Roberts MS. J Pharm Pharmacol; 2002 Mar; 54(3):373-82. PubMed ID: 11902803 [Abstract] [Full Text] [Related]
5. Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells. Lapicque F, Vergne P, Jouzeau JY, Loeuille D, Gillet P, Vignon E, Thomas P, Velicitat P, Türck D, Guillaume C, Gaucher A, Bertin P, Netter P. Clin Pharmacokinet; 2000 Nov; 39(5):369-82. PubMed ID: 11108435 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of lumiracoxib in plasma and synovial fluid. Scott G, Rordorf C, Reynolds C, Kalbag J, Looby M, Milosavljev S, Weaver M, Huff JP, Ruff DA. Clin Pharmacokinet; 2004 Nov; 43(7):467-78. PubMed ID: 15139795 [Abstract] [Full Text] [Related]
7. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio. Hinderling PH, Hartmann D, Crevoisier C, Moser U, Heizmann P. Ther Drug Monit; 1988 Nov; 10(3):250-60. PubMed ID: 3262939 [Abstract] [Full Text] [Related]
10. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis. Nichol FE, Samanta A, Rose CM. Drugs; 1988 Nov; 35 Suppl 1():46-51. PubMed ID: 3359945 [Abstract] [Full Text] [Related]
11. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis. Trnavská Z, Trnavský K. Eur J Clin Pharmacol; 1980 Nov; 18(5):403-6. PubMed ID: 7439262 [Abstract] [Full Text] [Related]
12. Hyaluronan secretion into the synovial cavity of rabbit knees and comparison with albumin turnover. Coleman PJ, Scott D, Ray J, Mason RM, Levick JR. J Physiol; 1997 Sep 15; 503 ( Pt 3)(Pt 3):645-56. PubMed ID: 9379418 [Abstract] [Full Text] [Related]
13. A prodrug approach involving in situ depot formation to achieve localized and sustained action of diclofenac after joint injection. Thing M, Ågårdh L, Larsen S, Rasmussen R, Pallesen J, Mertz N, Kristensen J, Hansen M, Østergaard J, Larsen CS. J Pharm Sci; 2014 Dec 15; 103(12):4021-4029. PubMed ID: 25354787 [Abstract] [Full Text] [Related]
15. A physiological pharmacokinetic model for solute disposition in tissues below a topical below a topical application site. Roberts MS, Cross SE. Pharm Res; 1999 Sep 15; 16(9):1392-8. PubMed ID: 10496655 [Abstract] [Full Text] [Related]
16. Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid. Bertin P, Lapicque F, Payan E, Rigaud M, Bailleul F, Jaeger S, Treves R, Netter P. Eur J Clin Pharmacol; 1994 Sep 15; 46(1):3-7. PubMed ID: 8005184 [Abstract] [Full Text] [Related]
18. Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation. Whiteman M, Haigh R, Tarr JM, Gooding KM, Shore AC, Winyard PG. Ann N Y Acad Sci; 2010 Aug 15; 1203():146-50. PubMed ID: 20716297 [Abstract] [Full Text] [Related]